Marpai, Inc. Secures \$12 Million Private Placement Led by Mitchell Companies
Key Points for Investors
- Marpai, Inc. (OTCQX: MRAI), a leader in healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, has announced a \$12 million private placement.
- The capital raise was led by Mitchell Companies and involved the issuance of newly designated convertible preferred stock to accredited investors.
- 12,100 shares of preferred stock were sold at \$1,000 per share, with an initial conversion price of \$1.00.
- Preferred shareholders are entitled to an 8% dividend, payable in common shares, upon liquidity events or conversion.
- Each share of preferred stock automatically converts to common shares upon a qualified public offering or a 60% holder vote.
- This investment is intended to accelerate Marpai’s strategic growth, enhance its technology-enabled platform, and strengthen its financial position.
Details of the Transaction
Marpai, Inc. has entered into securities purchase agreements with accredited investors, spearheaded by Mitchell Companies, for a \$12 million private placement. The transaction involves the issuance of 12,100 shares of newly created convertible preferred stock at \$1,000 per share. Notably, the preferred stock is convertible into common shares at an initial conversion price of \$1.00.
Upon a liquidity event or conversion to common stock, preferred shareholders will be entitled to receive an 8% dividend, payable in shares of common stock. Conversion of the preferred stock to common shares is automatic either upon a qualified public offering or if 60% of the preferred shareholders vote in favor.
The securities are not registered under the Securities Act of 1933 and cannot be sold in the United States without registration or exemption.
Strategic Implications and Shareholder Relevance
The infusion of \$12 million is designed to:
- Accelerate Marpai’s growth trajectory and scale its operations
- Advance the company’s technology roadmap
- Strengthen Marpai’s financial position to support its mission of delivering smarter, more efficient healthcare administration solutions
- Enable Marpai to further empower self-funded employers to optimize plan performance, reduce healthcare costs, and improve health outcomes for members through advanced, data-driven technology
CEO Damien Lamendola emphasized that this capital ensures Marpai is well-positioned to execute its strategic vision and capitalize on significant market opportunities. Mitchell Companies’ backing provides both financial resources and strategic alignment, reflecting confidence in Marpai’s leadership and long-term growth potential.
Potential Price-Sensitive Information
- Substantial Capital Injection: The \$12 million investment strengthens Marpai’s balance sheet and could improve perceptions of financial stability among investors.
- Convertible Preferred Stock Terms: The issuance of preferred stock with conversion features and an 8% dividend payable in common shares could impact future share dilution and dividend policies.
- Strategic Growth Plans: The stated use of proceeds to scale operations and technology could drive revenue growth and market positioning, important for future valuation.
- Leadership Confidence: Strong endorsement from Mitchell Companies and its chairman, Steve Mitchell, highlights confidence in Marpai’s executive team, particularly CEO Damien Lamendola.
Forward-Looking Statements and Risks
The press release includes statements about future expectations, including the anticipated impact of the private placement and the company’s ability to execute its strategic plans. These forward-looking statements are subject to risks such as changes in economic conditions, competition, market acceptance, and the challenges of managing business growth. Investors should be aware that actual results could differ materially from these expectations.
About Marpai and Mitchell Companies
- Marpai, Inc.: A healthcare technology company specializing in TPA and PBM services for self-funded employer health plans, aiming to improve plan performance and member outcomes.
- Mitchell Companies: A family office and investment platform focused on high-growth businesses across several sectors, including healthcare and technology-enabled services.
For more information about Marpai, investors can review filings with the SEC or contact Steve Johnson at [email protected].
Disclaimer: This article includes forward-looking statements that involve significant risks and uncertainties. Actual results may differ materially from those expressed or implied. This is not an offer to sell or a solicitation of an offer to buy any securities. Investors should perform their own due diligence and consult with financial advisors before making investment decisions. See Marpai’s SEC filings for additional information and risk factors.
